422 related articles for article (PubMed ID: 15311879)
21. The influence of stenting on the behavior of amino-oleic acid-treated, glutaraldehyde-fixed porcine aortic valves in a sheep model.
Ozaki S; Herijgers P; Verbeken E; Van Lommel A; Nishida T; Perek B; Zietkiewicz M; Leunens V; Flameng W
J Heart Valve Dis; 2000 Jul; 9(4):552-9; discussion 559-60. PubMed ID: 10947049
[TBL] [Abstract][Full Text] [Related]
22. Preimplant ultrastructure and calcification tendency of various biological aortic valves.
Mirzaie M; Meyer T; Schwartz P; Dalichau H
J Heart Valve Dis; 2000 Jul; 9(4):576-82. PubMed ID: 10947053
[TBL] [Abstract][Full Text] [Related]
23. Prevention of porcine aortic wall calcification by acellularization: necessity for a non-glutaraldehyde-based fixation treatment.
Meuris B; Verbeken E; Flameng W
J Heart Valve Dis; 2005 May; 14(3):358-63; discussion 363-4. PubMed ID: 15974531
[TBL] [Abstract][Full Text] [Related]
24. Role of glutaraldehyde in calcification of porcine heart valves: comparing cusp and wall.
Girardot MN; Torrianni M; Dillehay D; Girardot JM
J Biomed Mater Res; 1995 Jul; 29(7):793-801. PubMed ID: 7593017
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of different anticalcification treatments for stentless aortic bioprostheses.
Walther T; Falk V; Diegeler A; Rauch T; Weigl C; Gummert J; Autschbach R; Mohr FW
Thorac Cardiovasc Surg; 1999 Feb; 47(1):23-5. PubMed ID: 10218616
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of calcification with citric acid in pericardial bioprosthetic heart valve material: a preliminary report.
Sucu N; Tamer L; Aytacoglu B; Polat A; Dondas HA; Gul A; Dikmengil M; Atik U
J Heart Valve Dis; 2004 Jul; 13(4):697-700. PubMed ID: 15311880
[TBL] [Abstract][Full Text] [Related]
27. Bioprosthetic tissue calcification: influence of blood contact and arterial pressure. an experimental study in rats and sheep.
Meuris B; Ozaki S; Herijgers P; Verbeken E; Flameng W
J Heart Valve Dis; 2003 May; 12(3):392-9; discussion 399. PubMed ID: 12803341
[TBL] [Abstract][Full Text] [Related]
28. Prevention of calcification of bioprosthetic heart valve cusp and aortic wall with ethanol and aluminum chloride.
Clark JN; Ogle MF; Ashworth P; Bianco RW; Levy RJ
Ann Thorac Surg; 2005 Mar; 79(3):897-904. PubMed ID: 15734402
[TBL] [Abstract][Full Text] [Related]
29. Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcification by alcohol pretreatment: further mechanistic studies.
Vyavahare NR; Jones PL; Hirsch D; Schoen FJ; Levy RJ
J Heart Valve Dis; 2000 Jul; 9(4):561-6. PubMed ID: 10947050
[TBL] [Abstract][Full Text] [Related]
30. Characterizing the inflammatory reaction in explanted Medtronic Freestyle stentless porcine aortic bioprosthesis over a 6-year period.
Nair V; Law KB; Li AY; Phillips KR; David TE; Butany J
Cardiovasc Pathol; 2012; 21(3):158-68. PubMed ID: 21816627
[TBL] [Abstract][Full Text] [Related]
31. Effects of fixation back pressure and antimineralization treatment on the morphology of porcine aortic bioprosthetic valves.
Flomenbaum MA; Schoen FJ
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):154-64. PubMed ID: 8419696
[TBL] [Abstract][Full Text] [Related]
32. Role of elastin in pathologic calcification of xenograft heart valves.
Bailey MT; Pillarisetti S; Xiao H; Vyavahare NR
J Biomed Mater Res A; 2003 Jul; 66(1):93-102. PubMed ID: 12833435
[TBL] [Abstract][Full Text] [Related]
33. Factors influencing calcification of cardiac bioprostheses in adolescent sheep.
Flameng W; Meuris B; Yperman J; De Visscher G; Herijgers P; Verbeken E
J Thorac Cardiovasc Surg; 2006 Jul; 132(1):89-98. PubMed ID: 16798307
[TBL] [Abstract][Full Text] [Related]
34. Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potential.
Pathak CP; Adams AK; Simpson T; Phillips RE; Moore MA
J Biomed Mater Res A; 2004 Apr; 69(1):140-4. PubMed ID: 14999761
[TBL] [Abstract][Full Text] [Related]
35. A multi-step approach in anti-calcification of glutaraldehyde-preserved bovine pericardium.
Neethling WM; Hodge AJ; Clode P; Glancy R
J Cardiovasc Surg (Torino); 2006 Dec; 47(6):711-8. PubMed ID: 17043620
[TBL] [Abstract][Full Text] [Related]
36. The pulmonary bioprosthetic heart valve: its unsuitability for use as an aortic valve replacement.
Jennings LM; Butterfield M; Booth C; Watterson KG; Fisher J
J Heart Valve Dis; 2002 Sep; 11(5):668-78; discussion 679. PubMed ID: 12358404
[TBL] [Abstract][Full Text] [Related]
37. Kangaroo vs. porcine aortic valves: calcification potential after glutaraldehyde fixation.
Narine K; Chéry CC; Goetghebeur E; Forsyth R; Claeys E; Cornelissen M; Moens L; Van Nooten G
Eur Surg Res; 2005; 37(3):137-43. PubMed ID: 16088178
[TBL] [Abstract][Full Text] [Related]
38. Mitigation of calcification and cytotoxicity of a glutaraldehyde-preserved bovine pericardial matrix: improved biocompatibility after extended implantation in the subcutaneous rat model.
Neethling WM; Glancy R; Hodge AJ
J Heart Valve Dis; 2010 Nov; 19(6):778-85. PubMed ID: 21214104
[TBL] [Abstract][Full Text] [Related]
39. Tissue damage and calcification may be independent mechanisms of bioprosthetic heart valve failure.
Vesely I; Barber JE; Ratliff NB
J Heart Valve Dis; 2001 Jul; 10(4):471-7. PubMed ID: 11499593
[TBL] [Abstract][Full Text] [Related]
40. Diamine extension of glutaraldehyde crosslinks mitigates bioprosthetic aortic wall calcification in the sheep model.
Zilla P; Bezuidenhout D; Weissenstein C; van der Walt A; Human P
J Biomed Mater Res; 2001 Jul; 56(1):56-64. PubMed ID: 11309791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
